Struthers Richard Scott (CIK 1746298) reported 39 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Sell CRNX (1,000 shares), Sell CRNX (111,100 shares), Sell CRNX (136,805 shares), Sell CRNX (106,000 shares), Sell CRNX (110,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 1,000 | $85,000 |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 111,100 | $9.4M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 136,805 | $11.6M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 106,000 | $9.0M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 110,000 | $9.3M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 100,000 | $8.5M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 111,100 | $9.4M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 248,043 | $21.1M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 111,100 | $9.4M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 111,100 | $9.4M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 80,000 | $6.8M |
| 2026-09-01 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 176,663 | $15.0M |
| 2026-08-11 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Buy | 4,422 | $99,981 |
| 2026-08-11 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Buy | 6,542 | $100,027 |
| 2026-08-11 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Buy | 4,995 | $100,000 |
| 2026-08-11 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Buy | 3,969 | $99,979 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Buy | 111,100 | $0 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 222,200 | $0 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 222,200 | $0 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 80,000 | $0 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Buy | 222,200 | $0 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Buy | 80,000 | $0 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 111,100 | $0 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Sell | 111,100 | $0 |
| 2026-06-02 | Crinetics Pharmaceuticals, Inc. (CRNX) | President & CEO | Buy | 222,200 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01